OUR 9TH YEAR OF PROVIDING PROPRIETARY CAPITAL MARKETS INTELLIGENCE ON THE CANNABIS / HEMP / PSYCHEDELIC SECTORS

Valuation Tracker By Industry Sector

Valuation Tracker By Sector

The Viridian Value Tracker is the most comprehensive valuation product in the industry.

    • A broad set of 12 valuation measures assures applicability, regardless of whether the company has analyst coverage or revenues.  The typically presented EV/ Projected Revenues and EV/ Projected EBITDA are available for less than 1/3 of the cannabis companies we track.
    • Most valuation studies present only the average valuation measures, while the Tracker goes one step further and shows the distribution of values (the quartiles, median, and dispersion) for each measure. This gives users a more complete view of how companies in the cohort group are valued.

Week ended 09/13/2024

Weekly Sector Valuation Report – Cultivation and Retail Sector improvement since last week

  • Of the 36 companies with 2024 analysts’ estimates, the median EV/ 2024 Revenues are up slightly since last week, from 1.15x to 1.18x. The median EV/ 2024 EBITDA multiple is up more from 6.20x to 7.04x. These multiples continue to be significantly too low, given the regulatory progress towards S3, the re-emergence of SAFER Act discussions, and the fact that both candidates are supportive of further liberalization of cannabis laws.
  • Lower interest rates should tilt the scales toward growth investments like cannabis, but current valuations reflect neither the growth nor the value aspects of the large MSO stocks.

Week ended 09/13/2024

Weekly Sector Valuation Report – Cultivation and Retail Sector improvement since last week

  • Of the 36 companies with 2024 analysts’ estimates, the median EV/ 2024 Revenues are up slightly since last week, from 1.15x to 1.18x. The median EV/ 2024 EBITDA multiple is up more from 6.20x to 7.04x. These multiples continue to be significantly too low, given the regulatory progress towards S3, the re-emergence of SAFER Act discussions, and the fact that both candidates are supportive of further liberalization of cannabis laws.
  • Lower interest rates should tilt the scales toward growth investments like cannabis, but current valuations reflect neither the growth nor the value aspects of the large MSO stocks.

This Chart is Only Available to Higher Tier Memberships

Please Purchase a Premium or Enterprise membership to see more.